Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)
India · Delayed Price · Currency is INR 4,577.60
-13.80 (-0.30%)
At close: Dec 16, 2025
Sanofi Consumer Healthcare India Company Description
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India.
It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce.
The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited is a subsidiary of Opella Healthcare Participations B.V.
Sanofi Consumer Healthcare India Limited
| Country | India |
| Founded | 2023 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 583 |
| CEO | Himanshu Bakshi |
Contact Details
Address: Unit 1104, 11th Floor Mumbai, 400079 India | |
| Phone | 91 22 4528 8855 |
| Website | sanofi.com |
Stock Details
| Ticker Symbol | SANOFICONR |
| Exchange | National Stock Exchange of India |
| Fiscal Year | January - December |
| Reporting Currency | INR |
| ISIN Number | INE0UOS01011 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Himanshu Bakshi | MD and Director |
| Richard D'souza | Chief Financial Officer |
| Nikunjkumar Jaysukhlal Savaliya | Company Secretary, Compliance Officer& Head of Legal |